The Division of Health Policy and Insurance Research (HPI) studies effects of high-cost medical care (including consumer-directed health plans and high-deductible insurance), pharmaceutical policies, health insurance innovations (such as value-based insurance designs), personalized medicine, delivery system changes, opioid policy, physician workforce distribution, behavioral interventions, and cost-quality trade-offs.
Our mission: The Division of Health Policy and Insurance Research (HPI) seeks to produce rigorous evidence and build research capacity to inform policies and system innovations that improve health outcomes, especially among vulnerable populations. We engage in research and capacity-building in both the United States and around the world. During our more than 20-year history, HPI researchers have published groundbreaking studies on pharmaceutical use and health outcomes in large populations, methods for improving clinical decision-making, high-deductible health plan effects, and the health impacts of cost-containment policies. HPI is recognized for its work in the US, Europe, Canada, and low and middle-income countries. Faculty members have consulted on health policy issues for state, national, and international entities, including the US Congress.
The HPI logo communicates our mission to produce rigorous evidence (represented by the time series graph) for informing health policies (the surrounding arch) that affect large populations, including the most vulnerable among us (images of people from the very youngest to the elderly).